CANCER SUPPORT
1300 881 698
CANCER SUPPORT | 1300 881 698
Home » Insights & Articles
Have your say on treatments that matter to you
Nikki Rynia
Patients and their families impacted by upper gastrointestinal (GI) cancers are invited to share their lived experience on two therapies that are listed in the upcoming Pharmaceutical Benefits
Unite for Hope 2022: Echuca, Mansfield, Sydney and beyond!
Samantha Spokes
Our Unite for Hope fundraisers have raised nearly $70,000 so far! These vital funds help Pancare provide patient support services and fund research into early detection and new treatments. Our
Losing a parent in your 20’s.
“It gets easier over time”. I’ve heard that line a lot in the 24 years that I’ve been alive. Unfortunately, maybe more than most people my age it's because I lost my mother to cancer a few
Patients and their families impacted by Cholangiocarcinoma who have a specific IDH1 mutation (this mutation is found in the cancer of some people diagnosed with Cholangiocarcinoma), are invited to
Champion of Hope – Grant Rutley and the Inaugural BUGIC Grant Prix!
Drawing from his personal experience and battle with an upper GI cancer, Grant founded the BUGIC Foundation - to use his cancer experience to help as many people as he can who are also taking a
April is Oesophageal Cancer Awareness Month.
Chris Capstick
Oesophageal Cancer is considered a rare cancer with low survival rates and little recognition. Raising funds and awareness for Oesophageal cancer helps
February is Gallbladder and Bile Duct Cancer Awareness Month.
This year it is estimated that over 2226 Australians will be diagnosed with either gallbladder or biliary tract cancer. There is no early detection test, and there is a five-year survival rate of
Navigating the Festive Season
Has all the festive feasting got you feeling a little Bah-Humbug about the holiday season? You’re not alone. Food can bring up many challenges for someone with upper gastrointestinal cancer.
Medicines Update.
The Pharmaceutical Benefits Scheme (PBS), delivered welcomed news for Australians living with biliary cancer this week with IMFINZI® (durvalumab) being made available for patients diagnosed with
PBAC recommends subsidised therapies for biliary and oesophageal cancers
The Pharmaceutical Benefits Advisory Committee (PBAC) last week announced two positive recommendations for therapies that will benefit biliary and oesophageal cancer patients. The therapies brought
Cancer and Religious Fasting
We spoke to Senior Oncology Dietitian, Lauren Atkins, and pancreatic cancer patient, Aida, for their thoughts on how to navigate religious fasting periods if you or a loved one is impacted by